AstraZeneca's first quarter profits jump 74%

LONDON — Anglo-Swedish drugmaker AstraZeneca says first quarter earnings jumped 74%, buoyed by emerging markets and the success of new cancer treatments.

AstraZeneca said Friday that net income rose to $593 million from $340 million in the same period last year. Product sales increased 5.5% to $16.39 billion, driven by new drugs such as the bladder cancer treatment Imfinzi and lung cancer therapy Tagrisso.

Emerging market sales increased 14%, boosted by strong growth in China.

Nicholas Hyett, equity analyst at Hargreaves Lansdown in London, says the results vindicate CEO Pascal Soriot's strategy and show that "revenue growth is no longer a matter of faith" for investors.

Soriot promised investors that AstraZeneca's pipeline of new drugs would pay off when he fended off a takeover bid from Pfizer in 2014.

Must Read

Fans mourn pop's George Michael as charities...

Dec 26, 2016

Fans are mourning the death of pop star George Michael as British charities praise his generosity

Knighthoods for Murray and Farah in New Year's...

Dec 30, 2016

Andy Murray received a knighthood in Queen Elizabeth II's New Year's Honors list on Friday,...

Jamie Oliver to shut 6 UK restaurants in tough...

Jan 6, 2017

Celebrity chef Jamie Oliver is shutting six of his 42 Jamie's Italian restaurants in Britain amid...

Longtime British Vogue editor Alexandra Shulman...

Jan 25, 2017

The top editor at British Vogue plans to step down after a quarter century at the helm of the...

Britain to mark Queen Elizabeth II's record...

Feb 5, 2017

Queen Elizabeth II is poised for another historic milestone, an unprecedented 65 years on the throne

Sign up now!